In view of these findings, studies have focused on the role of TIMP-1 in the diagnosis and prognosis of patients with CRC, and many researchers have published data on its diagnostic value in CRC [17–18, 22–28]. This evidence concerns the gene TIMP1 and colorectal carcinoma.